Henderson John T. - 02 Dec 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Henderson
Issuer symbol
CYTK
Transactions as of
02 Dec 2025
Net transactions value
-$471,625
Form type
4
Filing time
02 Dec 2025, 17:14:16 UTC
Previous filing
16 Oct 2025
Next filing
16 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HENDERSON JOHN T Director 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO /s/ John O. Faurescu, attorney-in-fact for Dr. Henderson 02 Dec 2025 0001226488

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $87,500 +8,750 +12% $10.00 83,328 02 Dec 2025 Direct
transaction CYTK Common Stock Sale $559,125 -8,750 -11% $63.90 74,578 02 Dec 2025 Direct
holding CYTK Common Stock 83 02 Dec 2025 by Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -8,750 -100% $0.000000 0 02 Dec 2025 Common Stock 8,750 $10.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).